Impaired cardiac sympathetic innervation in symptomatic patients with long QTsyndrome

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 10, 2011, Pages 1899-1907

  Kies, Peter ^a   Paul, Matthias ^a   Gerss, Joachim ^b   Stegger, Lars ^a   Mönnig, Gerold ^a   Schober, Otmar ^a   Wichter, Thomas ^c   Schäfers, Michael ^b   Schulze Bahr, Eric ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MarienHospital Osnabruck   (Germany)

Author keywords

123I MIBG; Genotype; Long QTsyndrome; Scintigraphy; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ELECTROCARDIOGRAPHY; FEMALE; GENOTYPE; HEART ARREST; HUMAN; LONG QT SYNDROME; MALE; QT INTERVAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; SYNCOPE;

3-IODOBENZYLGUANIDINE; ADULT; AGED; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; GENOTYPE; HEART; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; NEURONS; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 80455174768     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1852-7     Document Type: Article

References (33)

1. Moss AJ. Long QTsyndrome. JAMA 2003;289:2041-4.
2. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95. (Pubitemid 32050441)
3. Wedekind H, Schwarz M, Hauenschild S, Djonlagic H, Haverkamp W, Breithardt G, et al. Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation. Clin Genet 2004;65:233-41. (Pubitemid 38239755)
4. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004;292:1341-4. (Pubitemid 39223225)
5. Viitasalo M, Oikarinen L, Swan H, Väänänen H, Järvenpää J, Hietanen H, et al. Effects of beta-blocker therapy on ventricular repolarization documented by 24-h electrocardiography in patients with type 1 long-QTsyndrome. J Am Coll Cardiol 2006;48:747-53. (Pubitemid 44175738)
6. Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Fuchsberger C, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 2009;41:407-14.
7. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 2009;41:399-406.
8. Kimbrough J, Moss AJ, Zareba W, Robinson JL, Hall WJ, Benhorin J, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation 2001;104:557-62. (Pubitemid 32738125)
9. Chevalier P, Rodriguez C, Bontemps L, Miquel M, Kirkorian G, Rousson R, et al. Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates. Cardiovasc Res 2001;50:386-98. (Pubitemid 32382166)
10. Yamanari H, Nakayama K, Morita H, Miyazi K, Fukushima K, Matsubara H, et al. Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome. Heart 2000;83:295-300. (Pubitemid 30313333)
11. Momose M, Kobayashi H, Kasanuki H, Kusakabe K, Tamaki A, Onishi S, et al. Evaluation of regional cardiac sympathetic innervation in congenital long QT syndrome using 123I-MIBG scintigraphy. Nucl Med Commun 1998;19:943-51. (Pubitemid 28520143)
12. Müller KD, Jakob H, Neuzner J, Grebe SF, Schlepper M, Pitschner HF. 123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome. Eur Heart J 1993;14:316-25. (Pubitemid 23103413)
13. Mazzadi AN, André-Fouët X, Duisit J, Gebuhrer V, Costes N, Chevalier P, et al. Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol 2003;285:H1286-93. (Pubitemid 37048187)
14. Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, et al. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation 1994;89:667-83.
15. Wichter T, Matheja P, Eckardt L, Kies P, Schäfers K, Schulze-Bahr E, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002;105:702-6. (Pubitemid 34157373)
16. Schäfers M, Wichter T, Lerch H, Matheja P, Kuwert T, Schäfers K, et al. Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 1999;40:1-5. (Pubitemid 29044163)
17. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993;88:782-4. (Pubitemid 23228078)
18. Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.
19. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-70.
20. Mönnig G, Eckardt L, Wedekind H, Haverkamp W, Gerss J, Milberg P, et al. Electrocardiographic risk stratification in families with congenital long QTsyndrome. Eur Heart J 2006;27:2074-80. (Pubitemid 44412814)
21. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, et al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 2003;21:651-2.
22. World Medical Association General Assembly. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects (revised October 7, 2000). HIV Clin Trials 2001;2:92-5.
23. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985;109:399-411. (Pubitemid 16248481)
24. Moss A, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000;101:616-23. (Pubitemid 30094732)
25. Bokil NJ, Baisden JM, Radford DJ, Summers KM. Molecular genetics of long QT syndrome. Mol Genet Metab 2010;101:1-8.
26. Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL, et al. Long QT syndrome in adults. J Am Coll Cardiol 2007;49:329-37. (Pubitemid 46097383)
27. Kaufman ES, Priori SG, Napolitano C, Schwartz PJ, Iyengar S, Elston RC, et al. Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol 2001;12:455-61. (Pubitemid 32324661)
28. Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, et al. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 2006;48:1047-52. (Pubitemid 44292467)
29. Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A 1996;93:2208-12. (Pubitemid 26079907)
30. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000;35:778-86. (Pubitemid 30167037)
31. Wichter T, Schäfers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy. Quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic β-adrenergic receptor density with positron emission tomography. Circulation 2000;101:1552-8. (Pubitemid 30180892)
32. Paul M, Schäfers M, Kies P, Acil T, Schäfers K, Breithardt G, et al. Impact of sympathetic innervation on recurrent lifethreatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 2006;33:866-70. (Pubitemid 44127434)
33. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 2009;53:426-35.